Goldman Sachs Group Inc Abb Vie Inc. Call Options Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $34.6 Million - $42.1 Million	211,000 Added 57.26%	579,500 $114 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $59.8 Million - $69.9 Million	-386,500 Reduced 51.19%	368,500 $63.2 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $50.4 Million - $57.5 Million	315,600 Added 71.83%	755,000 $137 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $19.9 Million - $22.4 Million	-144,800 Reduced 24.79%	439,400 $68.1 Million
Q3 2023 May 14, 2024	BUY	$133.59 - $154.65 $19.3 Million - $22.4 Million	144,800 Added 32.95%	584,200 $87.1 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $39 Million - $45.1 Million	291,700 Added 99.73%	584,200 $87.1 Million
Q2 2023 May 14, 2024	SELL	$132.51 - $164.9 $18.3 Million - $22.8 Million	-138,100 Reduced 32.07%	292,500 $39.4 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $18.3 Million - $22.8 Million	-138,100 Reduced 32.07%	292,500 $39.4 Million
Q1 2023 May 14, 2024	SELL	$144.61 - $166.54 $112 Million - $129 Million	-771,900 Reduced 64.19%	430,600 $68.6 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $112 Million - $129 Million	-771,900 Reduced 64.19%	430,600 $68.6 Million
Q4 2022 May 14, 2024	BUY	$138.31 - $165.87 $144 Million - $173 Million	1,040,200 Added 640.91%	1,202,500 $194 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $144 Million - $173 Million	1,040,200 Added 640.91%	1,202,500 $194 Million
Q3 2022 May 14, 2024	SELL	$134.21 - $153.93 $8.29 Million - $9.51 Million	-61,800 Reduced 27.58%	162,300 $21.8 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $8.29 Million - $9.51 Million	-61,800 Reduced 27.58%	162,300 $21.8 Million
Q2 2022 May 14, 2024	SELL	$137.62 - $174.96 $29.6 Million - $37.7 Million	-215,300 Reduced 49.0%	224,100 $34.3 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $25 Million - $31.8 Million	-182,000 Reduced 44.82%	224,100 $34.3 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $27.7 Million - $34.4 Million	-209,900 Reduced 34.07%	406,100 $65.8 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $8.01 Million - $10.1 Million	74,600 Added 13.78%	616,000 $83.4 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $57.6 Million - $65.4 Million	541,400 New	541,400 $58.4 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account